Showing results (151-160 of 1,815) with videos related to
Sort By:
Pageof 182
The British Journal of Radiology|February 20, 2016
Parotid gland lesions: separate and combined diagnostic value of conventional MRI, diffusion-weighted imaging and dynamic contrast-enhanced MRIYing Yuan, Weiqing Tang, Xiaofeng TaoClinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2018
Accuracy, Safety, and Reliability of Novel Phase I Trial DesignsHeng Zhou, Ying Yuan, Lei NieMedcomm|May 9, 2024
KEYNOTE-811: Potential to revise first-line therapy for metastatic human epidermal growth factor receptor 2-positive gastric cancerYuwei Ding, Ying Yuan, Shanshan WengAnnals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia|May 10, 2026
Transcervical Dumon Stenting via Longitudinal Tracheotomy for Recurrent Upper Tracheal Restenosis after Failed ResectionMu-Chou Lin, Ying-Yuan ChenJoint Commission Journal on Quality and Patient Safety|May 22, 2026
Association of Timing of Psychiatry Consultation and Length of Stay and Length of Stay Index in Hospitalized Patients with Cancer: Risk-Adjusted OutcomesDeepti Chopra, Noman Ali, Kodwo Dickson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2017
Keyboard: A Novel Bayesian Toxicity Probability Interval Design for Phase I Clinical TrialsFangrong Yan, Sumithra J Mandrekar, Ying YuanZhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics|January 20, 2009
[Effect of tacrolimus on growth-associated protein-43 expression in the hippocampus of neonatal rats with hypoxic-ischemic brain damage]Yan Zhou, Ying Xiong, San-Ying YuanNeuro-Oncology Practice|November 15, 2021
BOIN: a novel Bayesian design platform to accelerate early phase brain tumor clinical trialsYing Yuan, Jing Wu, Mark R GilbertDiscover Oncology|March 21, 2024
FAM83D acts as an oncogene by regulating cell cycle progression via multiple pathways in synovial sarcoma: a potential novel downstream target oncogene of anlotinibZi-Mei Liu, Ying Yuan, Lei JinBiometrics|February 16, 2024
A generalized phase 1-2-3 design integrating dose optimization with confirmatory treatment comparisonYong Zang, Peter F Thall, Ying YuanPageof 182